Evidence map›Paper›PMID 34848882›Full record

ReviewNature neuroscience2021

Cortical interneurons in autism.

Anis Contractor, Iryna M Ethell, Carlos Portera-Cailliau

Open access · greenAbstract readReview
In one paragraph

Review in Nature neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Intermittent Fasting andNutrients · 2026
    Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anis ContractorDepartment of Neuroscience Feinberg School of Medicine, Weinberg College of Arts and Sciences, Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-5131-2536
Iryna M EthellDivision of Biomedical Sciences, UC Riverside School of Medicine, Riverside, CA, USA.
Carlos Portera-CailliauDepartment of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. cpcailliau@mednet.ucla.edu.ORCID http://orcid.org/0000-0001-5735-6380
Northwestern University · USUniversity of California, Los Angeles · USUniversity of California, Riverside · US

Funding

Translational medicine and mechanistic studies of brain neurophysiology in Fragile X SyndromeU54HD104461 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI HUBER, KIMBERLY M. · 2020 to 2024
$8.1M
Imaging the origin of dendritic spine abnormalities in fragile X miceR01HD054453 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Carlos Portera-Cailliau · 2007 to 2026
$6.5M
The role of glutamate receptors in compulsive and perseverative behaviorR01MH099114 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CONTRACTOR, ANIS · 2012 to 2022
$4.5M
Deciphering the Roles of Kainate Receptors in Developing CNS CircuitsR01NS105502 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CONTRACTOR, ANIS, SWANSON, GEOFFREY T · 2018 to 2022
$2.6M
Cortical Interneuron Dysfunction in Fragile X SyndromeR01HD108370 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Anis Contractor, Carlos Portera-Cailliau · 2022 to 2026
$2.5M
Circuit Disruptions Underlying Atypical Sensory Processing in Fragile X SyndromeR01NS117597 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ERICKSON, CRAIG, PORTERA-CAILLIAU, CARLOS · 2020 to 2024
$2.3M
NICHD NIH HHS R01 HD054453NICHD NIH HHS R01 HD108370NICHD NIH HHS U54 HD104461NIMH NIH HHS R01 MH099114NINDS NIH HHS R01 NS105502NINDS NIH HHS R01 NS117597
6 · The paper itself

Abstract

The mechanistic underpinnings of autism remain a subject of debate and controversy. Why do individuals with autism share an overlapping set of atypical behaviors and symptoms, despite having different genetic and environmental risk factors? A major challenge in developing new therapies for autism has been the inability to identify convergent neural phenotypes that could explain the common set of symptoms that result in the diagnosis. Although no striking macroscopic neuropathological changes have been identified in autism, there is growing evidence that inhibitory interneurons (INs) play an important role in its neural basis. In this Review, we evaluate and interpret this evidence, focusing on recent findings showing reduced density and activity of the parvalbumin class of INs. We discuss the need for additional studies that investigate how genes and the environment interact to change the developmental trajectory of INs, permanently altering their numbers, connectivity and circuit engagement.

Indexed as

Autistic DisorderHumansInterneuronsParvalbuminsPhenotypeParvalbumins

Identifiers

PMID34848882
PMCPMC9798607
OpenAlexW3217454507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.